| 0.36 0.009 (2.62%) | 02-24 09:30 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 0.6  |
1-year : | 0.75 |
| Resists | First : | 0.52 |
Second : | 0.64 |
| Pivot price | 0.39 |
|||
| Supports | First : | 0.32 | Second : | 0.26 |
| MAs | MA(5) : | 0.37 |
MA(20) : | 0.41 |
| MA(100) : | 0.54 |
MA(250) : | 4.26 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 20.6 |
D(3) : | 22.6 |
| RSI | RSI(14): 39.7  |
|||
| 52-week | High : | 32 | Low : | 0.32 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ PTHL ] has closed above bottom band by 17.9%. Bollinger Bands are 48.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 0.37 - 0.37 | 0.37 - 0.37 |
| Low: | 0.35 - 0.36 | 0.36 - 0.36 |
| Close: | 0.36 - 0.36 | 0.36 - 0.36 |
Pheton Holdings Ltd, a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. The company's proprietary treatment planning system is a radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system is FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs at risks and produce dose distribution plan for brachytherapy for cancer patients. The company was founded in 1998 and is based in Beijing, China. Pheton Holdings Ltd operates as a subsidiary of ZJW (BVI) LTD.
Tue, 13 Jan 2026
Pheton Holdings Ltd Announces Corporate Name Change and Stock Ticker Symbol Change - Yahoo Finance
Fri, 05 Dec 2025
Pheton Holdings completes acquisition of 51% stake in iTonic - Investing.com
Fri, 05 Dec 2025
Pheton Holdings Ltd Announces Closing of Share Acquisition with iTonic Corporation - GlobeNewswire
Sat, 30 Aug 2025
Pheton Holdings Acquires Stake in Geri-Safe to Boost Medical Device Innovation - The Globe and Mail
Wed, 30 Jul 2025
AI for investors - MLQ.ai
Fri, 06 Sep 2024
Pheton Holdings Ltd Announces Closing of Initial Public Offering - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 0 (M) |
| Shares Float | 9 (M) |
| Held by Insiders | 7.45e+006 (%) |
| Held by Institutions | 20.5 (%) |
| Shares Short | 26 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -2.52e+006 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -3 % |
| Return on Assets (ttm) | 81.9 % |
| Return on Equity (ttm) | -49 % |
| Qtrly Rev. Growth | 305210 % |
| Gross Profit (p.s.) | 0.04 |
| Sales Per Share | 0.04 |
| EBITDA (p.s.) | -0.09 |
| Qtrly Earnings Growth | -0.2 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -3 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 7.53 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 17070 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|